Performing gynecologic cancer surgery during the COVID-19 pandemic in Turkey: A multicenter retrospective observational study
![Thumbnail](/xmlui/bitstream/handle/20.500.12511/5972/Ozdemir%2c%20Isa%20A.-2020.pdf.jpg?sequence=6&isAllowed=y)
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2020Yazar
Dursun, PolatDervişoğlu, Haluk
Daggez, Mine
Turan, Taner
Kılıç, Fatih
Moraloğlu Tekin, Özlem
Üreyen, Işın
Toptaş, Tayfun
Demirayak, Gökhan
Önder, Ayşe Büşra
Çelik, Çetin
Bayramoğlu, Denizhan
Güzel, Ahmet Barış
Arıöz, Dağıstan Tolga
Bilir, Filiz
Özdemir, İsa Aykut
Taşçı, Tolga
Karalök, Alper
Karateke, Ateş
Üst veri
Tüm öğe kaydını gösterKünye
Dursun, P., Dervişoğlu, H., Daggez, M., Turan, T., Kılıç, F., Moraloğlu Tekin, Ö. ... Karateke, A. (2020). Performing gynecologic cancer surgery during the COVID-19 pandemic in Turkey: A multicenter retrospective observational study. International Journal of Gynecology and Obstetrics, 151(1), 33-38. https://dx.doi.org/10.1002/ijgo.13296Özet
Objective To report the perioperative outcomes of 200 patients with gynecologic cancer who underwent surgery during the Novel Coronavirus Disease (COVID-19) pandemic and the safety of surgical approach. Methods Data of patients operated between March 10 and May 20, 2020, were collected retrospectively. Data were statistically analyzed using IBM Statistical Package for the Social Sciences (SPSS) Statistics for Windows v. SP21.0. Results Data of 200 patients were included. Their mean age was 56 years. Of the patients, 54% (n=108), 27.5% (n=55), 12.5% (n=25), and 2% (n=4) were diagnosed as having endometrial, ovarian, cervical, and vulvar cancer, respectively. Of them, 98% underwent non-emergent surgery. A minimally invasive surgical approach was used in 18%. Stage 1 cancer was found in 68% of patients. Surgeons reported COVID-related changes in 10% of the cases. The rate of postoperative complications was 12%. Only two patients had cough and suspected pneumonic lesions on thoracic computed tomography postoperatively, but neither was positive for COVID-19 on polymerase chain reaction testing. Conclusion Based on the present findings, it is thought that gynecologic cancer surgery should continue during the COVID-19 pandemic while adhering to the measures. Postponement or non-surgical management should only be considered in patients with documented infection. Gynecologic cancer surgery should continue during the COVID-19 pandemic while adhering to measures. Only 1% of patients developed COVID-19-related symptoms during the postoperative follow-up period.
WoS Q Kategorisi
Q1Scopus Q Kategorisi
Q2Kaynak
International Journal of Gynecology and ObstetricsCilt
151Sayı
1Koleksiyonlar
- Makale Koleksiyonu [3790]
- PubMed İndeksli Yayınlar Koleksiyonu [4251]
- Scopus İndeksli Yayınlar Koleksiyonu [6601]
- WoS İndeksli Yayınlar Koleksiyonu [6677]